Our Technologies

Renovos offers a portfolio of products to meet the needs of the orthopaedic regenerative medicine industry, by supporting researchers with novel solutions, and by addressing the unmet clinical needs within the orthopaedic space.

Our commercial proposition includes research-grade human bone marrow mesenchymal stem cells and a high-value screening services in a low-impact animal model for testing of novel materials and compounds for biocompatibility, toxicology, angiogenesis and regeneration (bone/cartilage).

Renovos is also developing its proprietary nanoclay technologies for safer and more efficient localised delivery of bone-healing compounds.

lab technician with pipette